证券代码：688571 证券简称：杭华股份 公告编号：2025-052 减持计划的进展情况 公司于 2025 年 9 月 26 日在上海证券交易所网站（www.sse.com.cn）披露《杭 华油墨股份有限公司关于回购股份集中竞价减持计划的公告》（公告编号： 2025-049），公司计划自该公告披露之日起 15 个交易日后的 3 个月内，通过集 中竞价交易方式，按照市场价格累计减持不超过 4,241,707 股已回购股份，占公 司总股本的 1%。若此期间公司发生送红股、资本公积金转增股本等导致公司股 本总数变动的情形，公司将对减持股份数量进行相应调整。 2025 年 10 月 27 日，公司首次出售已回购股份 110,000 股，减持均价为 8.29 元/股。截至本公告披露日，公司回购专用证券账户通过集中竞价方式减持公司 股份 110,000 股，占公司总股本的 0.03%，现将有关减持进展情况公告如下： 杭华油墨股份有限公司 1 关于回购股份集中竞价减持股份进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责 ...

Core Points - The company guarantees the authenticity, accuracy, and completeness of the quarterly report, and assumes legal responsibility for any false records or misleading statements [2][3][4] Financial Data - The financial statements for the third quarter are unaudited [3] - The report period refers to the three-month period from the beginning to the end of the quarter [3] - The company has not identified any non-recurring gains or losses for this reporting period [4] Shareholder Information - As of the end of the reporting period, Hanghua Ink Co., Ltd. holds 7,563,368 shares, accounting for 1.78% of the total share capital [6] Audit Information - The financial statements are unaudited, and the company has not executed new accounting standards or interpretations that would affect the financial statements for the current year [8]

Core Insights - The company reported a revenue of 336,038,374.58 yuan for the third quarter of 2025, representing a year-on-year growth of 0.80% [1] - The net profit attributable to shareholders of the listed company was 29,431,529.17 yuan, showing a year-on-year decline of 28.80% [1] Financial Performance - Revenue for Q3 2025: 336,038,374.58 yuan, up 0.80% year-on-year [1] - Net profit for Q3 2025: 29,431,529.17 yuan, down 28.80% year-on-year [1]

Group 1 - Company Hanghua Co., Ltd. reported third-quarter performance with revenue of approximately 907 million yuan, a year-on-year decrease of 1.62% [1] - The net profit attributable to shareholders of the listed company was about 75.94 million yuan, reflecting a year-on-year decline of 25% [1] - Basic earnings per share stood at 0.18 yuan, also down by 25% compared to the previous year [1] Group 2 - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market's activity, which is thriving, while the primary market is experiencing a fundraising slowdown [1]

Core Viewpoint - Hanghua Co., Ltd. (688571.SH) reported a slight increase in revenue for the third quarter, but experienced a significant decline in net profit compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 336 million yuan in the third quarter, representing a year-on-year growth of 0.80% [1] - The net profit attributable to shareholders was 29.43 million yuan, reflecting a year-on-year decrease of 28.80% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 27.98 million yuan, down 29.32% year-on-year [1] - Basic earnings per share were reported at 0.07 yuan [1]

Financial Performance - The company's revenue for Q3 2025 was CNY 336,038,374.58, representing a year-on-year increase of 0.80%[4] - Total profit for the period decreased by 38.54% to CNY 29,605,030.93 compared to the same period last year[9] - Net profit attributable to shareholders was CNY 29,431,529.17, down 28.80% year-on-year[4] - Basic earnings per share decreased by 30.00% to CNY 0.07[5] - Total operating revenue for the first three quarters of 2025 was CNY 907,110,655.28, a decrease of 1.05% compared to CNY 922,078,655.61 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 72,923,321.09, down 27.8% from CNY 100,993,185.97 in the previous year[20] - Earnings per share (EPS) for the first three quarters of 2025 was CNY 0.18, compared to CNY 0.24 in the same period of 2024[20] - Total profit for the first three quarters of 2025 was CNY 76.09 million, down 22.14% from CNY 97.83 million in the first three quarters of 2024[27] Expenses and Costs - Research and development expenses totaled CNY 13,646,628.03, accounting for 4.06% of revenue, a decrease of 0.87 percentage points[5] - Total operating costs increased to CNY 830,855,948.57, up 2.68% from CNY 814,309,359.50 year-over-year[18] - Research and development expenses for the first three quarters of 2025 were CNY 37,990,356.53, a decrease of 7.3% compared to CNY 41,109,773.80 in 2024[18] - Research and development expenses for the first three quarters of 2025 were CNY 31.67 million, a decrease of 8.00% from CNY 34.74 million in the first three quarters of 2024[27] - The company's sales expenses increased to CNY 37.81 million in the first three quarters of 2025, up 3.39% from CNY 36.57 million in the same period of 2024[27] Assets and Liabilities - Total assets increased by 7.91% to CNY 2,211,623,060.82 compared to the end of the previous year[5] - The company's total assets as of September 30, 2025, amount to ¥2,211,623,060.82, an increase from ¥2,049,432,035.11 as of December 31, 2024[14] - Current assets total ¥1,548,150,433.50, down from ¥1,637,394,342.83 in the previous period[15] - Total liabilities increased to ¥533,622,924.76 from ¥473,156,353.88[16] - The company's equity increased to ¥1,677,000,136.06 from ¥1,576,275,681.23[16] - The company's total assets and equity increased to CNY 2,211,623,060.82 and CNY 1,678,000,136.06 respectively, compared to CNY 2,049,432,035.11 and CNY 1,576,275,681.23 in the previous year[17] - The company’s total liabilities and equity increased by 7.9% year-over-year[17] - The total liabilities increased to ¥387,696,324.41 from ¥322,954,409.42, which is an increase of about 20%[25] - The total equity rose slightly to ¥1,482,257,946.44 from ¥1,477,978,784.01, indicating a marginal increase of around 0.2%[25] Cash Flow - The company reported a cash flow from operating activities of CNY 144,482,414.65, an increase of 13.48% year-to-date[4] - Cash flow from operating activities totaled CNY 789,126,671.65, slightly down from CNY 789,864,610.23 in the previous year[20] - The net cash flow from operating activities increased to ¥144,482,414.65 from ¥127,317,014.95, representing a growth of approximately 13.4% year-over-year[21] - The company reported a net cash outflow from investing activities of CNY 172.72 million in the first three quarters of 2025, compared to a net outflow of CNY 92.83 million in the same period of 2024[30] - The cash and cash equivalents at the end of the first three quarters of 2025 were CNY 623.77 million, an increase from CNY 509.08 million at the end of the same period in 2024[30] - The company's cash flow from operating activities was positive, while both investment and financing activities resulted in net outflows, indicating a need for strategic financial management[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,168[11] - The largest shareholder, Hangzhou Industrial Investment Group Co., Ltd., holds 156,000,000 shares, accounting for 36.78% of total shares[11] - The number of shares held by the top 10 shareholders remains unchanged, with no shares lent out through margin trading[13] Market Conditions and Strategic Focus - The decline in profit was attributed to weak market demand and intensified price competition, along with costs from ongoing projects[9] - The company is currently in the cultivation stage of new acquisition projects, which are impacting profitability due to initial investments[9] - The company has not reported any significant changes in operational strategies or new product developments during the reporting period[12] - The company plans to continue focusing on research and development to enhance product offerings and market competitiveness[27]

杭华油墨股份有限公司 总经理工作细则 杭华油墨股份有限公司 总经理工作细则 第一章 总则 第一条 为进一步完善杭华油墨股份有限公司（以下简称"公司"）的法人 治理结构，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《杭华油墨 股份有限公司章程》（以下简称"《公司章程》"）及有关法律、法规的规定，制定 本工作细则。 第二章 总经理的任职资格与任免程序 第二条 总经理的任职资格： （一）具有较为丰富的经济理论知识、管理知识及较强的经营管理能力； （二）具有调动员工积极性、建立合理的组织机构、协调各种内外关系和统 揽全局的能力； （三）具有一定年限的企业管理或经济工作经历，精通本行，熟悉生产经营 业务，熟悉国家有关政策、法律、法规，具有一定的财会知识及税务知识； （四）诚信勤勉、廉洁奉公、民主公道； （五）年富力强，具有强烈的使命感和积极开拓的进取精神。 第三条 有下列情形之一的，不得担任公司总经理： （一）无民事行为能力或者限制民事行为能力； （二）因犯有贪污、贿赂、侵占财产、挪用财产罪或者破坏社会经济秩序罪， 被判处刑罚，或者因犯罪被剥夺政治权利，执行期满未逾五年，被宣告缓刑的， 自缓刑考验期满之日起 ...

杭华油墨股份有限公司 董事会战略委员会工作细则 杭华油墨股份有限公司 董事会战略委员会工作细则 第一章 总 则 第一条 为适应公司战略发展需要，增强公司核心竞争力，确定公司发展规划， 健全投资决策程序，加强决策科学性，提高重大决策的效率和决策水平，完善公司 治理结构，根据《中华人民共和国公司法》《上市公司治理准则》《杭华油墨股份有 限公司章程》（以下简称"《公司章程》"）及其他有关规定，公司特设董事会战略委 员会并制定本工作细则。 第二条 战略委员会是董事会下设的专门工作机构，主要工作是对公司长期发 展战略和重大投资决策进行研究并向公司董事会提出建议、方案。 第二章 人员组成 第三条 战略委员会成员由三名董事组成，其中至少 1 名独立董事。 第四条 战略委员会委员由董事会选举产生。 1 / 4 杭华油墨股份有限公司 董事会战略委员会工作细则 第五条 战略委员会设召集人一名，负责主持战略委员会工作；由董事会选举 产生。 第六条 战略委员会任期与董事会任期一致，委员任期届满连选可连任。期间 如有委员不再担任公司董事职务，其委员资格即自行解除，公司应按本细则规定进 行及时补选。 第七条 公司董事会办公室负责战略委员 ...

杭华油墨股份有限公司 董事会审计委员会工作细则 第三条 审计委员会成员由 3 名不在公司担任高级管理人员的董事组成，其中独 立董事应当过半数，委员中至少有 1 名独立董事为专业会计人士，全部委员应当具 备履行审计委员会工作职责的专业知识和经验。 第四条 审计委员会委员由董事会选举产生。 第五条 审计委员会设召集人 1 名，由独立董事中会计专业人士担任，负责主持 委员会工作。召集人须具备会计或财务管理相关的专业经验，由董事会选举产生。 委员会召集人负责召集和主持委员会会议， 召集人不能履行或者不履行职务的， 由过半数的审计委员会成员共同推荐 1 名成员召集和主持。 审计委员会任期与董事会任期一致，委员会任期届满，可连选连任。除非出现 《公司法》《公司章程》或本工作细则规定不得任职的情形，不得被无故解除职务。 杭华油墨股份有限公司 董事会审计委员会工作细则 第一章 总 则 第一条 为强化杭华油墨股份有限公司（以下简称"公司"）董事会决策功能， 做到事后审计、专业审计，确保董事会对管理层的有效监督，完善公司治理结构， 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《杭华油墨股份有限公司 章程》（以下简称" ...

杭华油墨股份有限公司 董事会提名委员会工作细则 第一章 总则 第一条 为规范杭华油墨股份有限公司（以下简称"公司"）董事、高级管理人 员的选聘工作，优化董事会组成，完善公司治理结构，根据《中华人民共和国公司 法》《上市公司治理准则》《杭华油墨股份有限公司章程》（以下简称"《公司章程》"） 及其他有关规定，公司董事会特设立提名委员会，并制定本工作细则。 第二条 提名委员会是董事会下设的专门工作机构，主要负责对《公司章程》所 规定的具有提名权的提名人所提名的董事和高级管理人员的任职资格进行选择和建 议，向董事会报告，对董事会负责。 第三条 本规则所称董事包括内部董事、独立董事；高级管理人员指：公司总经 理、副总经理、总工程师、财务负责人、董事会秘书及由总经理提请董事会认定的 其他高级管理人员。 第二章 人员组成 杭华油墨股份有限公司 董事会提名委员会工作细则 第四条 提名委员会成员由三名董事组成，其中独立董事占多数。 第五条 提名委员会委员由董事会选举产生。 第六条 提名委员会设召集人 1 名，由独立董事委员担任，负责主持提名委员会 工作；由董事会选举产生。 第七条 提名委员会任期与董事会任期一致，委员任期届满连 ...